ATHENS A newly published study led by researchers from the University of Georgia and several partner institutions reveals a discovery that could lead to new control strategies for a tiny-but-persistent agricultural pest that causes enormous soybean losses.
Microscopic soybean cyst nematodes (SCN) live in soil and are attracted to the root systems of soybeans. Once a field is infested, it is nearly impossible to root them out, according to lead study investigator Melissa Mitchum, professor of plant nematology in UGAs Department of Plant Pathology and Institute of Plant Breeding, Genetics and Genomics in the College of Agricultural and Environmental Sciences and Center for Applied Genetic Technologies.
Invisible to the naked eye, SCN have unique hollow, protrudable mouth spears called stylets that they use to pierce through the root of a plant, injecting peptide effectors, which mimic the soybeans naturally present CLAVATA3/embryo (CLE) surrounding region peptides to hijack the plant.
After hatching from an egg in the soil, the juvenile nematode migrates into the root, where it sets up a feeding site and makes its way toward the circulatory system that the plant uses to transport nutrients to the rest of the plant.
Once a root cell is chosen for feeding, the nematodes transform it into a syncytium, a mass comprising hundreds of metabolically active cells that continue to secrete CLE, taking over the plants natural cellular processes to export the peptides back out of the cell to function as external signaling molecules to distant cells.
This process diverts resources away from the plant in support of the nutrient demands of the developing nematode. At this point, nematodes change their morphology, turning from wormlike forms into sedentary, lemon-shaped bodies that pop out of the roots, becoming visible to the eye.
Using knowledge that has been developed over the past two decades on how nematode CLEs function, the study, published in the journal New Phytologist, uncovered a new pathway that allows the nematode to disrupt the plants natural growth processes to divert resources for its own benefit. The study also was highlighted in commentary by the editors of New Phytologist.
Weve discovered that early on, when the nematode delivers the CLE peptide to a root cell, the peptide has to reach a plant receptor that binds it so that you get a response in the plant, Mitchum said. We knew that the nematode delivered the peptide into the cytoplasm of the cell, but the receptor is on the outside of the cell.
The study shows that the nematode CLEs provide a way for the nematode peptide to get outside of the cell to interact with the plant protein receptor through the plants secretion system, a process that is not well-studied in plants.
To me it is fascinating because the nematodes have discovered how to co-opt that part of the plant its own secretion system but we dont understand the secretion system they are taking advantage of, Mitchum said. If we can understand how they are doing it, we will likely uncover some novel aspect of plant biology that could have importance to other plant pathosystems. This effector protein is helping us understand plant biology, not just plant pathology.
Normally occurring plant CLE peptides regulate aspects of cell differentiation in the plant, communicating to the plants stem cells, which are constantly regenerating, whether to develop into a root cell, a leaf cell or a cell in another part of the plant.
The next step is to find novel methods to block the nematode peptides from getting out of the feeding cells.
We are trying to figure out how these nematode peptides function because we want to devise a way to interfere with that ability, Mitchum said. If we can block the nematode peptides from getting out of the feeding cells, they will not form properly, and the nematode loses its nutrient source and dies.
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Soybean cyst nematodes are the No. 1 yield-reducing pest of soybean producers, robbing seemingly healthy fields of up to 30% of their yields and costing the industry up to $1 billion every year.
The primary management practice for soybean cyst nematodes is through developing genetic resistance in soybean varieties. Because SCN has a specialized host range, producers can control nematode damage by rotating fields to a non-host crop plant to reduce the population of nematodes in the field. However, the bodies of dead female nematodes form a cyst around them, protecting hundreds of eggs. These cysts can remain in the ground for years, protecting the eggs until a host crop is planted again and the nematodes reemerge.
While creating genetically resistant crops is an effective tool, SCN have adapted to overcome the source of resistance in the commonly used breeding line PI 88788, which is used in more than 90% of resistant varieties currently planted by producers. As a result, yields in resistant varieties can be reduced by up to 14 bushels per acre, according to The SCN Coalition, a public/private partnership of university researchers, national extension specialists and agriculture company representatives who are concerned about the evolving threat from soybean cyst nematodes.
We need to bring awareness to the increased resistance of SCN to the (PI 88788) resistance and come up with novel approaches to combat it, Mitchum said. Targeting the mechanism we have found in this study would be a novel way of addressing this resistance.
Because soybean cyst nematodes are such a widespread pest, Mitchum and UGA Extension plant pathologist Bob Kemerait, with the help of county agents, will launch a statewide survey in 2021 of all soybean-producing counties in Georgia to determine current SCN levels and whether SCN-resistant crops are suffering greater losses due to the nematodes adaptations against resistant varieties.
While Georgia is not a major producer of soybeans with 100,000 acres planted in 2019 at a value of about $240,000 more than 80 million acres were planted nationwide in 2019, with a production value of $31.2 billion, according to the U.S. Department of Agricultures National Agriculture Statistics Service.
From a genetic standpoint, we are working with soybean breeders to diversify the germplasm and working with companies to get new SCN-resistant varieties out to producers while, in parallel, we are doing this kind of basic science research to understand the mechanisms used by the nematode to cause disease so we can interfere with them in a novel way, Mitchum said.
Bringing awareness to the importance of basic science and basic research is a message that needs to come through when discoveries like this are made, she noted.
A lot of times the return on research investment is not as immediate or apparent as it is if you go out and do a field trial and get immediate results, Mitchum said. There has to be a balance we need to invest in research that will have an immediate impact, but if we are going to come up with breakthrough technologies, it is going to be from an investment in this kind of long-term research.
Lead study author Jianying Wang was a former research associate in Mitchums lab. Research partners in the multi-institutional study included Richard S. Hussey, Emeritus Distinguished Research Professor of Nematology at CAES; and CAGT post-doctoral researcher Xunliang Liu; as well as colleagues from University of Missouri, Worcester Polytechnic Institute, Iowa State University, North Carolina State University and Cornell University. Mitchum joined UGA in 2019 from the University of Missouris Division of Plant Sciences and Bond Life Sciences Center.
Funding for this work was from the National Science Foundation and the USDA National Institute of Agricultures Agriculture and Food Research Initiative.
Go here to read the rest:
Invisible pest causes more than $1 billion in crop losses - The Albany Herald
- Israeli-Based 3D-Printed Lab-Grown Meat Company is Building World's ... - December 27th, 2022
- Scientists Discover Protein Partners that Could Heal Heart Muscle | Newsroom - UNC Health and UNC School of Medicine - October 13th, 2022
- Global Synthetic Stem Cells Market Is Expected To Reach Around USD 42 Million By 2025 - openPR - October 13th, 2022
- A Look Into the Next Century After 100 Years of Insulin - Cureus - October 13th, 2022
- Grafting and Budding Nursery Crop Plants - North Carolina State University - October 4th, 2022
- Lifting up NC Teachers of the Year and TFA alumni - EdNC - August 22nd, 2022
- Vegan Oysters in Shells? This Startup Just Developed a Prototype to Save the Oceans - VegNews - July 27th, 2022
- How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more - KYMA - July 19th, 2022
- Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation... - July 3rd, 2022
- W-S organization working on regenerative therapies for 40 organs, tissues - WRAL TechWire - July 3rd, 2022
- BioRestorative Therapies Annou - GuruFocus.com - July 3rd, 2022
- How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety - WYFF4 Greenville - June 13th, 2022
- Pediatric Urologist Dr. Anthony Atala to Receive 2022 Jacobson Innovation Award of the American College of Surgeons for Pioneering Work in... - June 13th, 2022
- The Soybean Plant | NC State Extension Publications - June 4th, 2022
- A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. - June 4th, 2022
- Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting - Yahoo... - April 6th, 2022
- Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT - Yahoo Finance - November 22nd, 2021
- Cytovia and Cellectis Expand Their TALEN Gene-Edited iNK Partnership to Enable Broader ... - The Bakersfield Californian - November 22nd, 2021
- Study Underway to Evaluate New PD-1/CD3 Antibody in T-cell Lymphoma - Targeted Oncology - October 28th, 2021
- What it means to be the worlds first IVF baby - THE WEEK - August 31st, 2021
- Cellectis Announces Participation in Five Investor Conferences - Yahoo Finance - August 31st, 2021
- Nanodecoy Therapy is an Effective Alternative to Neutralize SARS-CoV-2 Virus - AZoNano - June 23rd, 2021
- 'Nanodecoy' Therapy Binds and Neutralizes SARS-CoV-2 Virus - NC State News - June 23rd, 2021
- Researchers curb local immune response in horses receiving stem cell injury therapy - Horsetalk - February 7th, 2021
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now - February 7th, 2021
- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion - Reuters - January 13th, 2021
- Chancellor Harold L. Martin, on His Plan to Safely Open the Nation's Largest HCBU During COVID-19 - TIME - August 23rd, 2020
- Inside the race to ditch formula and grow breast milk in the lab - Wired.co.uk - August 23rd, 2020
- Study finds little evidence to back cord-blood therapy for autism - Spectrum - June 12th, 2020
- Balding men could grow hair back in weeks thanks to 'miracle potion' - Daily Star - May 19th, 2020
- Treatment in clinical trial offers options to woman fighting return of cancer (+ video) - WRAL Tech Wire - February 28th, 2020
- Searching for the 'big break' that could turn stem cells into a weapon against dementia - Genetic Literacy Project - February 28th, 2020
- Why Some COVID-19 Cases Are Worse than Others - The Scientist - February 28th, 2020
- The Future of Bioprinting Research Has a New Road Map - 3DPrint.com - February 14th, 2020
- Top Florida Medical Spa, Amnion of Florida, Partners With Merakris Therapeutics to Advance Their Non-Surgical Treatment Options - Business Wire - December 11th, 2019
- Synthetic Stem Cells Market Is Expecting Revolutionary Growth 2019 with Top Key Players: North Carolina State University (NCSU), Zhengzhou University... - December 6th, 2019
- Clinic pitches unproven treatments to desperate patients, with tips on raising the cash - Seattle Times - December 6th, 2019
- Reviewing vTv Therapeutics Inc. (VTVT)'s and Asterias Biotherapeutics Inc. (:)'s results - MS Wkly - October 27th, 2019
- Reviewing BioCryst Pharmaceuticals Inc. (BCRX)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 27th, 2019
- Global Synthetic Stem Cells Market Estimated to Reach USD 42 Million By 2025 - Daily Market Updates - September 29th, 2019
- Global Synthetic Stem Cells Market to Accumulate Revenues Worth US $42 Million By 2025 - ZMR News Research - September 24th, 2019
- Heal Yourself: How Exosome Therapy Can Repair Age-Damaged Skin - Market Research Finance - September 24th, 2019
- Cesca Therapeutics Inc. (KOOL) Can't Be More Safe. Trades Significantly Higher - Invest Tribune - September 24th, 2019
- Stem Cell Winston Salem North Carolina 27150 - April 5th, 2019
- Clinical Trial for Autism - cordbloodbank.com - March 8th, 2019
- Stem Cell Chapel Hill North Carolina 27514 - February 11th, 2019
- Alumna to compete for Miss America crown on Sunday - UNCSA - February 3rd, 2019
- Stem Cell Therapy Latest Research Charlotte, North Carolina - December 2nd, 2018
- Stem Cell Therapy North Carolina | Regenerative Medicine ... - October 4th, 2018
- Bone Marrow Transplant | Durham, Raleigh, North Carolina ... - July 24th, 2018
- Charlotte, North Carolina - Stem Cells Transplant Institute - July 15th, 2018
- Stem Cell Greensboro North Carolina 27455 - July 15th, 2018
- Spotlights Archive | The University of North Carolina at ... - October 15th, 2017
- Stem Cells in Focus - Blog - Closer Look at Stem Cells - October 10th, 2017
- Avalon Advisors Has Decreased Its Comcast Cmn Class (CMCSA) Position; Neuralstem (CUR)'s Sentiment Is 0 - High Point Observer - September 6th, 2017
- Former basketball star Greg Friel in fight of his life - Fosters - Foster's Daily Democrat - August 15th, 2017
- Lung fibrosis? Stem cell therapy holds promise - The Hindu - The Hindu - August 11th, 2017
- Stem cells may treat lung fibrosis diseases - Futurity: Research News - August 11th, 2017
- CRISPR Edits Genome of Human Embryos - Alzforum - August 11th, 2017
- Cary NC Stem Cell Treatment | Cary North Carolina Cancer ... - November 16th, 2016
- Cato - Research Triangle Park, Durham, North Carolina - August 21st, 2016
- Biotechnology Teacher Resources Online | North Carolina ... - August 19th, 2016
- Stem Cell Research in North Carolina ... Whats Really ... - August 5th, 2016
- JCI - Type 2 alveolar cells are stem cells in adult lung - October 19th, 2015
- Cary North Carolina Stem Cell Research | Cary NC Stem Cell ... - July 2nd, 2015
- Core labs | North Carolina Biotech Center - April 29th, 2015
- Image: Human endothelial cells experiment bound for ISS - February 26th, 2015
- COPD Prognosis Stem Cells Canada, COPD Alternative ... - February 17th, 2015
- Cancer Care Northwest Stem Cell Transplantation - January 10th, 2015
- Dying child approved for new treatment testing - January 2nd, 2015
- New e-Incubator enables real-time imaging of bioengineered tissues in controlled unit - November 5th, 2014
- Committee on Development, Regeneration, and Stem Cell ... - October 31st, 2014
- Local doctor uses stem cells to heal - October 29th, 2014
- Study Offers Fertility Preservation Option to Young Boys with Cancer - October 1st, 2014
- Fayetteville North Carolina Stem Cell Research ... - September 16th, 2014
- Charlotte NC Resources - Stem Cells: Get Facts on Uses ... - September 1st, 2014
- For the first time, researchers isolate adult stem cells ... - August 26th, 2014
- The Man Who Grew Eyes From Scratch - August 26th, 2014
- Carolina Stem Cell Treatment Center | carolina stem ... - August 22nd, 2014
- North Carolina Stem Cell Treatment | Stem Cell Treatments - August 22nd, 2014